Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M83.6Revenue $M4.1Net Margin (%)-162.4Z-Score12.4
Enterprise Value $M51.6EPS $-0.2Operating Margin %-152.9F-Score3
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-162.4Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %-16.9Quick Ratio10.5Cash flow > EarningsN
Price/Sales11.05-y EBITDA Growth Rate %4.1Current Ratio10.5Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-48.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-56.0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M48.9ROI % (ttm)-82.8Gross Margin Increase y-yN

Gurus Latest Trades with PRAN

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

PRAN is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


PRAN: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about PRAN :

    Quarterly/Annual Reports about PRAN:

      News about PRAN:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      The Lancet Neurology Publishes Prana's Huntington Disease Trial Nov 19 2014
      The Lancet Neurology Publishes Prana's Huntington Disease Trial Nov 19 2014
      Horizon Pharma's Actimmune Gets Orphan Drug Designation Oct 07 2014
      Prana Biotechnology Up on Orphan Drug Status for PBT2 Sep 08 2014
      US STOCKS-S&P 500 ends at record as jobs report eases Fed worries Sep 05 2014
      US STOCKS-S&P 500 ends at record as jobs report eases Fed worries Sep 05 2014
      US STOCKS-Wall St rises as weak payrolls ease Fed worries Sep 05 2014
      US STOCKS-Wall St rises as weak payrolls ease Fed worries Sep 05 2014
      US STOCKS-Wall St flat following weak payrolls report Sep 05 2014
      US STOCKS-Wall St flat following weak payrolls report Sep 05 2014
      Huntington’s Disease Orphan Drug Designation Could Rescue Prana Sep 05 2014
      US STOCKS-Wall St little changed after weak payrolls report Sep 05 2014
      US STOCKS-Wall St little changed after weak payrolls report Sep 05 2014
      Why Prana Biotechnology (PRAN) Stock Is Surging Today Sep 05 2014
      US STOCKS-Wall St set to dip at open after payrolls report Sep 05 2014
      US STOCKS-Wall St set to dip at open after payrolls report Sep 05 2014
      US STOCKS-Futures dip before payrolls; on track for weekly fall Sep 05 2014
      US STOCKS-Futures dip before payrolls; on track for weekly fall Sep 05 2014
      Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease Sep 05 2014
      3 Biotech Stocks Under $10 in Breakout Territory Aug 29 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK